Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Fuji Pharma Co Ltd (4554)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,555.0 +9.0    +0.58%
26/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3816200004 
  • Volume: 27,700
  • Bid/Ask: 1,551.0 / 1,556.0
  • Day's Range: 1,536.0 - 1,556.0
Fuji Pharma Co Ltd 1,555.0 +9.0 +0.58%

4554 Balance Sheet

 
Featured here, the Balance Sheet for Fuji Pharma Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 40400 39114 38297 38925
Cash and Short Term Investments 2161 2324 3975 5282
Cash - - - -
Cash & Equivalents 2161 2324 3975 5282
Short Term Investments - - - -
Total Receivables, Net 16746 16520 14997 14401
Accounts Receivables - Trade, Net 16737 16304 14585 14228
Total Inventory 20830 19371 18524 17772
Prepaid Expenses - - - -
Other Current Assets, Total 663 899 801 1470
Total Assets 84583 85332 84393 84803
Property/Plant/Equipment, Total - Net 21179 20547 19820 18998
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 332 412 492 551
Intangibles, Net 9999 10081 9493 9572
Long Term Investments 6147 14702 16137 16623
Note Receivable - Long Term 9 216 412 173
Other Long Term Assets, Total 5208 1 1 2
Other Assets, Total 6065 4225 4481 4973
Total Current Liabilities 27710 29771 28844 25582
Accounts Payable 6775 5672 7108 7083
Payable/Accrued - - - -
Accrued Expenses 264 883 474 627
Notes Payable/Short Term Debt 11300 11300 11300 10300
Current Port. of LT Debt/Capital Leases 3647 5724 5943 3436
Other Current liabilities, Total 5724 6192 4019 4136
Total Liabilities 42601 44156 43951 44353
Total Long Term Debt 12423 11924 12439 15947
Long Term Debt 7983 8683 9083 12493
Capital Lease Obligations 4440 3241 3356 3454
Deferred Income Tax - - 215 -
Minority Interest 2 2 2 2
Other Liabilities, Total -27916 -31334 -31952 -30191
Total Equity 41982 41176 40442 40450
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 3799 3799 3799 3799
Additional Paid-In Capital 4409 4409 4409 4409
Retained Earnings (Accumulated Deficit) 31348 29082 27629 27832
Treasury Stock - Common -554 -567 -567 -567
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2980 4453 5172 4977
Total Liabilities & Shareholders' Equity 84583 85332 84393 84803
Total Common Shares Outstanding 24.31 24.3 24.3 24.3
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4554 Comments

Write your thoughts about Fuji Pharma Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email